Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
BioRestorative Therapies, Inc. BRTX
$4.93
-$0.15 (-3.06%)
На 16:50, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
19214862.00000000
-
week52high
5.19
-
week52low
2.46
-
Revenue
119800
-
P/E TTM
-1
-
Beta
61.88789000
-
EPS
-5.02000000
-
Last Dividend
0.00000000
-
Next Earnings Date
27 мар 2023 г. в 06:00
Описание компании
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Roth Capital | Buy | 01 дек 2021 г. | |
| Maxim Group | Buy | 28 сент 2022 г. | |
| Roth Capital | Buy | 07 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| ALSTODT LANCE | A | 187321 | 400 | 01 февр 2023 г. |
| ALSTODT LANCE | A | 186921 | 200 | 27 янв 2023 г. |
| ALSTODT LANCE | A | 186721 | 100 | 20 янв 2023 г. |
| ALSTODT LANCE | A | 186621 | 100 | 20 янв 2023 г. |
| ALSTODT LANCE | A | 186521 | 100 | 18 янв 2023 г. |
| ALSTODT LANCE | A | 186421 | 100 | 18 янв 2023 г. |
| ALSTODT LANCE | A | 186321 | 200 | 18 янв 2023 г. |
| ALSTODT LANCE | A | 186121 | 100 | 09 янв 2023 г. |
| ALSTODT LANCE | A | 186021 | 100 | 23 дек 2022 г. |
| ALSTODT LANCE | A | 185921 | 200 | 23 дек 2022 г. |
Новостная лента
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event
Newsfile Corp
17 янв 2023 г. в 09:29
Melville, New York--(Newsfile Corp. - January 17, 2023) - BioRestorative Therapies (NASDAQ: BRTX) ("BioRestorative", "BRTX" or the "Company"), a clinical stage company focused on stem cell-based therapies, announced today that management will be presenting at the virtual Investor Summit. During the presentation, BioRestorative Therapies Chief Executive Officer, Lance Alstdot, will highlight the Company's regenerative medicine platform and technology.
BioRestorative Therapies to Present at the Dawson James Securities 7th Annual Small Cap Growth Conference
GlobeNewsWire
28 сент 2022 г. в 07:00
MELVILLE, NY., Sept. 28, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will be presenting at the Dawson James Securities 7th Annual Small Cap Growth Conference on October 12, 2022 at the Wyndham Grand Hotel in Jupiter, Florida.